Acutus Medical, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Acutus Medical's 2024 10-K filing reveals a company in transition, marked by strategic restructuring, operational downsizing, and delisting from Nasdaq, as it focuses on its manufacturing partnership with Medtronic.
OTC.Pink
Acutus Medical is restructuring its business to focus solely on manufacturing left-heart access products for Medtronic, discontinuing its mapping and ablation businesses.